Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Ferris, Robert L and Cohen, Ezra and Gash, Kelly and Whiting, Sam and Manjarrez, Kristi and Dietsch, Greg and Hershberg, Robert and Bryan, James (2014) Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Journal for ImmunoTherapy of Cancer, 2 (Suppl ). P69 - P69. ISSN 2051-1426

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (153kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Ferris, Robert Lrlf1@pitt.eduRLF1
Cohen, Ezra
Gash, Kelly
Whiting, Sam
Manjarrez, Kristi
Dietsch, Greg
Hershberg, Robert
Bryan, James
Centers: Other Centers, Institutes, Offices, or Units > Pittsburgh Cancer Institute
Date: 2014
Date Type: Publication
Journal or Publication Title: Journal for ImmunoTherapy of Cancer
Volume: 2
Number: Suppl
Publisher: BMJ
Page Range: P69 - P69
DOI or Unique Handle: 10.1186/2051-1426-2-s3-p69
Schools and Programs: School of Medicine > Otolaryngology
Refereed: Yes
ISSN: 2051-1426
Date Deposited: 21 Dec 2016 20:51
Last Modified: 18 Mar 2021 10:56
URI: http://d-scholarship.pitt.edu/id/eprint/29464

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item